🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rationale: Visual hallucinations (VH) are the most common non-motor symptom...
Status
Terminated
Location
Academic Medical Center
Start Date
2013-11
Trial ID
NCT01856738
Treatments Being Tested
Current therapeutic approaches for the treatment of neurodegenerative disea...
Status
Completed
Location
Loghman Hospital
Start Date
2011-01
Trial ID
NCT01696123
Treatments Being Tested
This study is being conducted to determine the safety, tolerability, and ph...
Status
Completed
Location
Pacific Research Network, Inc.
Start Date
2008-10
Trial ID
NCT00766363
We are studying subjects with mild to moderate Alzheimer's disease who have...
Status
Completed
Location
The Litwin-Zucker Research Center
Start Date
2007-08
Trial ID
NCT00551161
Treatments Being Tested
The current project proposes the comparison of two pharmacologic strategies...
Status
Completed
Location
Fundació LLuita contra la SIDA
Start Date
2011-05
Trial ID
NCT01348282
Treatments Being Tested
Butyrylcholinesterase (BuChE) activity is increasing in Alzheimer Disease (...
Status
Unknown
Location
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Start Date
2014-02
Trial ID
NCT02063269
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01399125
The purpose of this study is to determine if short term use of rivastigmine...
Status
Completed
Location
Kennedy Krieger Institute
Start Date
2009-11
Trial ID
NCT01084135
Treatments Being Tested
The purpose of this study is to collect and compare information regarding t...
Status
Completed
Location
Multiple Locations
Start Date
2002-07
Trial ID
NCT00291421
Lewy body spectrum disorders are a common group of neurodegenerative diseas...
Status
Completed
Location
Sunnybrook Health Sciences Centre
Start Date
2006-09
Trial ID
NCT01944436
Treatments Being Tested